US78397T1117 - SABSW (XNAS)

SAB Biotherapeutics, Inc. - Warrant Acción

0,13 USD

32,90 % 0,03 USD 08.01.2025 21:41 - USD - NASDAQ (XNAS) - Precios actuales y gráficos en MoneyPeak

Cotizaciones actuales de SAB Biotherapeutics, Inc. - Warrant

Bolsa	Ticker	Moneda	Última operación	Precio	Variación diaria	Variación diaria %
NASDAQ	SABSW	USD	08.01.2025 21:41	0,13 USD	0,10 USD	32,90 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	114,35 %	165,80 %	427,38 %	121,87 %	453,75 %	-91,14 %

Company Profile for SAB Biotherapeutics, Inc. - Warrant Share

SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV). SAB Biotherapeutics, Inc. was incorporated in 2014 and is based in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts.

Company Data for SAB Biotherapeutics, Inc. - Warrant Share

Name SAB Biotherapeutics, Inc. - Warrant

Company SAB Biotherapeutics, Inc.

Symbol SABSW

Website http://www.sabbiotherapeutics.com

Primary Exchange

NASDAQ

ISIN US78397T1117

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Samuel J. Reich

Market Capitalization 25 Mio

Country United States of America

Currency USD

Employees 0,1 T

Address 2100 East 54th Street North, 33140 Sioux Falls

IPO Date 2021-10-25

ID Changes

Date	From	To
25.10.2021	BCYPW	SABSW

Ticker Symbols

Name	Symbol
NASDAQ	SABSW

More Shares

Investors who SAB Biotherapeutics, Inc. - Warrant hold also have the following shares in their portfolio:

AB S.I-INT.TECHNOLOGIESPTF.A DL Fonds

INVESTEC BANK PLC K/O NTS CAR 26/08/22 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Jobs Community Feedback Changelog